RNA urine test outperforms standard bladder cancer tests and could help guide treatment

Дата публикации: 02-10-2026 09:00:01

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder cancer more accurately than current standard methods. The test also allows physicians not only to assess the cancer's response to treatment but also to predict whether immunotherapy or chemotherapy is likely to be most effective for each patient.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies	5	7	18-04-2024
2	Urinary Biomarkers: Is the Era of Exclusive Follow-Up Cystoscopy Coming to an End? A Mini-Review of Emerging Molecular Diagnostics and Risk-Stratified Surveillance	0	8.06	08-04-2026
3	New Combination Therapy Shows Promise for Advanced Bladder Cancer	0	11.16	06-08-2026
4	"Клинические рекомендации "Рак мочевого пузыря" (одобрены Минздравом России)	0	6.69	15-10-2026
5	Разработаны системы для диагностики рака эндометрия и рака мочевого пузыря	0	0	17-09-2025
6	New blood test for noncoding RNA significantly improves cancer detection	7	8	31-08-2023
7	New treatment approach improves survival, reduces recurrence risk in muscle-invasive bladder cancer	0	11.13	24-07-2026
8	Новый анализ крови от ученых США может выявлять рак на ранней стадии	0	11.9	13-08-2026
9	Researchers develop mathematical measures to better personalize therapy for prostate cancer	0	7.4	13-08-2026
10	STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer	0	12.07	15-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.49. Источник: medicalxpress.com.